Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms
Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms
NCT ID: NCT06398236 Phase: NA Status: COMPLETED Enrollment: 170 Completion: 2024-10-16
Conditions
Menopause
Interventions
SE5-OH tablets
Summary
Multicentre, exploratory, prospective, open-labelled study to evaluate the efficacy of SE5-OH tablets on menopausal symptoms in healthy women experiencing menopausal symptoms after 12 weeks of administration.
The study will be performed in 10 hospitals (private and public) located in Spain. Recruitment period of 6 months will be defined in order to include up to 300 healthy volunteers from different national hospitals and clinics.
Primary Outcome
To evaluate the efficacy of SE5-OH tablets on menopausal symptoms.